A new disease level precision medicine model; starting with melanoma
In just a few months, the PM Connective expects to complete a new model for melanoma that will offer clinical and financial benefits in precision healthcare. Early indicators suggest the model
will provide substantial improvements in health outcomes and lower overall healthcare costs by shifting the entire management of melanoma from the expense of treating late stage disease to
earlier interventions when, significantly, this aggressive condition is curable.